Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-Seq in LNCaP prostate cancer cells

ABSTRACT: ChIP-Seq in LNCaP prostate cancer cells

PROVIDER: PRJNA643562 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12129946.fastq.gz	Fastqsanger.gz
	SRR12129947.fastq.gz	Fastqsanger.gz
	SRR12129948.fastq.gz	Fastqsanger.gz
	SRR12129949.fastq.gz	Fastqsanger.gz
	SRR12129950.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 32

Similar Datasets

LNCaP prostate cancer cells

Project description:LNCaP prostate cancer cells

| PRJNA801659 | ENA

FoxA1 inhibits androgen receptor expression and suppresses prostate cancer metastasis [LNCaP, ChIP-seq]

Project description:FoxA1 has been shown critical for prostate development and prostate-specific gene expression regulation. In addition to its well-established role as an AR pioneering factor,several studies have recently revealed significant AR binding events in prostate cancer cells with FoxA1 knockdown. Furthermore, the role of FoxA1 itself in prostate cancer has not been carefully examined. Thus, it is important to understand the role of FoxA1 in prostate cancer and how it interacts with AR signaling. To address these questions, we generated LNCaP cells with stable FoxA1 knockdown. We performed AR/FoxA1 ChIP-seq and microarray analysis of these cells. ChIP_Seq examination of AR and FoxA1 binding sites in LNCaP shCtrl and shFoxA1 cells

2014-06-02 | E-GEOD-37345 | biostudies-arrayexpress

MeDIP and ChIP-on-chip data from normal Prostate epithelial cells (PrEC) and the LNCaP cancer cell line

Project description:To identify genomic regions which display concordant epigenetics alterations in prostate cancer, we performed MeDIP and ChIP-on-chip profiling of normal prostate epithelial cells (PrEC) and the prostate cancer cell line LNCaP. These promoter arrays were integrated with expression arrays of the same cells to discover and characterise regions of Long Range Epigenetic Silencing (LRES) in prostate cancer.

2010-01-04 | GSE19600 | GEO

RNA-sequencing in LNCaP prostate cancer cells

Project description:RNA-sequencing in LNCaP prostate cancer cells

| PRJNA801669 | ENA

The cistrome of NKX3.1 in LNCaP prostate cancer cells

Project description:Here we report the genome-wide set of factors bound by NKX3.1 or control IgG in human prostate cancer cells (LNCaP). Examination of NKX3.1 binding in LNCaP prostate cancer cells

2013-08-21 | E-GEOD-40269 | biostudies-arrayexpress

FoxA1 inhibits androgen receptor expression and suppresses prostate cancer metastasis [LNCaP, ChIP-seq]

2014-06-02 | GSE37345 | GEO

Expression data from normal Prostate epithelial cells (PrEC) and the LNCaP cancer cell line

Project description:To identify genomic regions which display concordant gene expression in prostate cancer, we performed expression profiling of normal prostate epithelial cells (PrEC) and the prostate cancer cell line LNCaP. These expression arrays were integrated ChIP-on-chip studies of active and repressive epigenetic marks in same cells to discover and characterise regions of Long Range Epigenetic Silencing (LRES) in prostate cancer.

2010-01-04 | GSE19725 | GEO

Genome-wide characterization of REST binding regions in LNCaP prostate cancer cells

Project description:Transcriptional regulator REST plays a key role in repressing neuronal specific genes in prostate cancer and other non-neuronal tissues. Moreover, loss of REST is observed in neuroendocrine prostate tumors. Here, we use ChIP-seq analysis to study genome–wide REST occupied regions in the prostate cancer cell line, LNCaP. REST occupied regions were then correlated to gene expression changes occurring between prostate adenocarcinoma and neuroendocrine prostate tumors in vivo.

2019-09-03 | GSE119385 | GEO

ChIP-Seq in LNCaP prostate cancer cells

Project description:We used ChIP-Seq to profile AR binding and H3K27 acetylation genome-wide in LNCaP cells with and without PRMT inhibition and knockdown.

2022-01-28 | GSE153661 | GEO

TMEFF2 isoform detection in LNCaP prostate cancer cells

Project description:TMEFF2 isoform detection in LNCaP prostate cancer cells

| PRJNA693813 | ENA